Population pharmacokinetics of intravenous valproic acid in Korean patients.
about
Population pharmacokinetics of valproic acid in pediatric patients with epilepsy: considerations for dosing spinal muscular atrophy patientsObesity and overweight as CAE comorbidities and differential drug response modifiers.The effect of uridine diphosphate glucuronosyltransferase (UGT)1A6 genetic polymorphism on valproic acid pharmacokinetics in Indian patients with epilepsy: a pharmacogenetic approach.Sex related differences on valproic acid pharmacokinetics after oral single dose.A Systematic Review of Population Pharmacokinetics of Valproic Acid.
P2860
Population pharmacokinetics of intravenous valproic acid in Korean patients.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Population pharmacokinetics of intravenous valproic acid in Korean patients.
@en
Population pharmacokinetics of intravenous valproic acid in Korean patients.
@nl
type
label
Population pharmacokinetics of intravenous valproic acid in Korean patients.
@en
Population pharmacokinetics of intravenous valproic acid in Korean patients.
@nl
prefLabel
Population pharmacokinetics of intravenous valproic acid in Korean patients.
@en
Population pharmacokinetics of intravenous valproic acid in Korean patients.
@nl
P2093
P2860
P1476
Population pharmacokinetics of intravenous valproic acid in Korean patients.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2710.2002.00440.X
P577
2002-12-01T00:00:00Z